Background Which patients should receive dual therapy as initial treatment for chronic obstructive pulmonary disease (COPD) is only loosely defined. We evaluated if a lower …
A Angelakas, C Vlachopoulos… - Current Respiratory …, 2013 - ingentaconnect.com
Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide. Its morbidity and mortality are increasing and it is predicted to be the third leading cause of death by …
Background: Which patients should receive dual therapy as initial treatment for chronic obstructive pulmonary dis‑ease (COPD) is only loosely defined. We evaluated if a lower …
Η χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ) είναι φλεγμονώδης, ετερογενής πάθηση, με παθολογοανατομικές και παθοφυσιολογικές αποκλίσεις, κλινικές παραλλαγές και …
AG Mathioudakis… - Archives of Hellenic …, 2014 - search.ebscohost.com
Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory disease with pathological and pathophysiological variations, clinical subtypes and extrapulmonary …